ANI Pharmaceuticals reports Q3 2022 results; financial details not provided in filing excerpt

ANI PHARMACEUTICALS INC

2022-Q3 EPS reported -$2.76 revenue$222,153,000

Company reported financial and operating results for Q3 2022 ended September 30, 2022.
Exhibit 99.1 contains conference call transcript but no specific financial figures in provided excerpt.
Investors should refer to full press release for revenue, EPS, and segment details.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ANI PHARMACEUTICALS INC reported financial results for the three and nine months ended September 30, 2022.

Period: the three and nine months ended September 30, 2022
Result: reported results

Exact text from the filing

On November 9, 2022, ANI Pharmaceuticals, Inc. (“ANI”) issued a press release announcing its financial and operating results for the three and nine months ended September 30, 2022.

View on SEC.gov

Browse all earnings releases →

ANI PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-22-116545

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.